more information
Search within Results:

Select All    Deselect All
 | 
Citations
 | 
   print
Baselga, J., Pfister, D., Cooper, M. R., Cohen, R., Burtness, B., Bos, M., et al. (2000). Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J Clin Oncol, 18(4), 904–914.
more information
Brzustewicz, E., & Bryl, E. (2015). The role of cytokines in the pathogenesis of rheumatoid arthritis--Practical and potential application of cytokines as biomarkers and targets of personalized therapy. Cytokine, 76(2), 527–536.
more information
Burak, M. F., Inouye, K. E., White, A., Lee, A., Tuncman, G., Calay, E. S., et al. (2015). Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes. Sci Transl Med, 7(319), 319ra205.
more information
Chu, D. T., & Klymkowsky, M. W. (1989). The appearance of acetylated alpha-tubulin during early development and cellular differentiation in Xenopus. Dev Biol, 136(1), 104–117.
more information
Chu, D. T., & Klymkowsky, M. W. (1989). The appearance of acetylated alpha-tubulin during early development and cellular differentiation in Xenopus. Dev Biol, 136(1), 104–117.
more information
Overholser, J. P., Prewett, M. C., Hooper, A. T., Waksal, H. W., & Hicklin, D. J. (2000). Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice. Cancer, 89(1), 74–82.
more information
Seshacharyulu, P., Ponnusamy, M. P., Haridas, D., Jain, M., Ganti, A. K., & Batra, S. K. (2012). Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets, 16(1), 15–31.
more information
Select All    Deselect All
 | 
Citations
 | 
   print

Save Citations: